Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US13670691Application Date: 2012-11-07
-
Publication No.: US08735398B2Publication Date: 2014-05-27
- Inventor: Omar D. Lopez , Denis R. St. Laurent , Jason Goodrich , Jeffrey Lee Romine , Michael Serrano-Wu , Fukang Yang , Ramesh Kakarla , Xuejie Yang , Yuping Qiu , Lawrence B. Snyder
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07D249/08
- IPC: C07D249/08 ; C07D231/12 ; C07D413/14 ; C07D233/58 ; A61K31/4196 ; A61K31/4245 ; A61K31/415
Abstract:
The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
Public/Granted literature
- US20130085147A1 Hepatitis C Virus Inhibitors Public/Granted day:2013-04-04
Information query
